No Impact on IGF-1 or Blood Sugar Levels Unlike full growth hormone therapy, which can increase IGF-1 and affect glucose metabolism, AOD-9604: Does not elevate IGF-1 levels, reducing the risk of unwanted anabolic effects or organ enlargement
These data highlight the importance of sustained therapy or transition strategies (e.g., tapering, lifestyle reinforcement, or switching to maintenance agents) to prevent rapid rebound after treatment discontinuation
Wilding, John P
A discusso tambm enfatiza a importncia da avaliao individual de pacientes que consideram o uso da semaglutida, levando em conta as contraindicaes e os potenciais benefcios, a fim de tomar decises informadas sobre o tratamento (BAGGIO
They can be obtained from your GP surgery, local pharmacy, or NHS trust
When combined, you may experience something called orthostatic hypotension